本页面由Tiger Trade Technology Pte. Ltd.提供服务

Larimar Therapeutics, Inc.

3.66
+0.22506.56%
成交量:137.56万
成交额:490.41万
市值:3.13亿
市盈率:-1.87
高:3.73
开:3.42
低:3.38
收:3.43
52周最高:5.37
52周最低:1.61
股本:8,559.04万
流通股本:4,514.94万
量比:0.96
换手率:3.05%
股息:- -
股息率:- -
每股收益(TTM):-1.9534
每股收益(LYR):-1.3159
净资产收益率:-78.24%
总资产收益率:-42.99%
市净率:2.25
市盈率(LYR):-2.78

数据加载中...

2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/08

重要事件披露

8-K - Current report
2020/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/12

重要事件披露

8-K/A [Amend] - Current report
2020/11/10

重要事件披露

8-K - Current report
2020/10/30

重要事件披露

8-K - Current report
2020/10/02

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/09/29

重要事件披露

8-K/A [Amend] - Current report
2020/09/29

重要事件披露

8-K - Current report
2020/08/31

SEC问询函

CORRESP [Cover] - Correspondence
2020/08/14

重要事件披露

8-K/A [Amend] - Current report
2020/08/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]